No profile data available.
MabCure, Inc. (MBCI) is a technology company in the audio-visual chip components industry, based in White Plains, United States, with about 3 full-time employees.
It reported revenue of $500,000 for fiscal year 2011, and net income of -$12.26 million. Its market capitalization was $78 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2011; market data as of October 8, 2026.
, a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers.
MabCure reported $500,000 in revenue for fiscal year 2011.
$78 as of October 8, 2026.
Listed companies of a similar size in the same industry (audio-visual chip components) include Natcore Technology Inc. (NTCXF), Solar Park Initiatives, Inc. (SOPV), New Energy Exchange Ltd. (EBODF), Solar Thin Films, Inc. (SLTZ).